BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6601585)

  • 1. The effect of peripheral blood adherent cells from patients with aplastic anemia on in vitro hematopoiesis.
    Hanada T; Abe T
    Exp Hematol; 1983 Apr; 11(4):298-304. PubMed ID: 6601585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.
    Bacigalupo A; Podestà M; Mingari MC; Moretta L; Van Lint MT; Marmont A
    J Immunol; 1980 Oct; 125(4):1449-53. PubMed ID: 6967904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia.
    Hsu HC; Tsai WH; Chen LY; Hsu ML; Ing-Tiau Kuo B; Ho CH; Lin CK; Wang SY
    Exp Hematol; 1996 Jan; 24(1):31-6. PubMed ID: 8536789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of monocyte-conditioned medium on in vitro hematopoiesis.
    Hanada T; Nagasawa T; Abe T
    Exp Hematol; 1982 Aug; 10(7):561-7. PubMed ID: 6957306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia.
    Hoffman R; Zanjani ED; Lutton JD; Zalusky R; Wasserman LR
    N Engl J Med; 1977 Jan; 296(1):10-3. PubMed ID: 830263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent hemopoietic precursors in vitro (CFUMIX) in aplastic anemia.
    Hara H; Kai S; Fushimi M; Taniwaki S; Okamoto T; Ohe Y; Fujita S; Noguchi K; Senba M; Hamano T; Kanamaru A; Nagai K
    Exp Hematol; 1980 Oct; 8(9):1165-71. PubMed ID: 7227471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum stem cell factor levels in patients with aplastic anemia.
    Nimer SD; Leung DH; Wolin MJ; Golde DW
    Int J Hematol; 1994 Oct; 60(3):185-9. PubMed ID: 7532030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppression of in vitro hemopoiesis by the monocytes in a patient with aplastic anemia associated with hepatitis].
    Ishiguro A; Nakahata T; Amano Y; Koike K; Komiyama A; Shimbo T
    Rinsho Ketsueki; 1992 Jan; 33(1):87-92. PubMed ID: 1312181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of in vitro treatment with indomethacin on mouse granulocyte-macrophage colony-forming cells in culture (CFUC). Possible role of prostaglandins.
    Fontagné J; Adolphe M; Semichon M; Zizine L; Lechat P
    Exp Hematol; 1980 Oct; 8(9):1157-64. PubMed ID: 7227470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Th1 cell in the pathogenesis of aplastic anemia].
    He H; Shao Z; He G; Liu H; Shi J; Fu R; Zhao M; Bai J; Jia H; Sun J; Cui Z; Chu Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):574-7. PubMed ID: 12482340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of in vitro colony (CFUC) formation and myelosuppressive activity in patients with severe aplastic anemia after autologous hematologic reconstitution.
    Bacigalupo A; Podesta' M; Raffo MR; Piaggio G; Van Lint MT; Vimercati R; Spriano VM; Risso M; Marmont AM
    Exp Hematol; 1980 Jul; 8(6):795-801. PubMed ID: 7202583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interleukin 10 on the hematopoietic progenitor cells from patients with aplastic anemia.
    Asano Y; Shibata S; Kobayashi S; Okamura S; Niho Y
    Stem Cells; 1999; 17(3):147-51. PubMed ID: 10342557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term cultures of marrow cells from the patients with aplastic anemia].
    Fujiwara M
    Nihon Ketsueki Gakkai Zasshi; 1990 May; 53(3):533-40. PubMed ID: 2386006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory activity of T cells on hematopoiesis and gamma-IFN production by T cells from peripheral blood in patients with aplastic anemia].
    Hanada T; Yamamura H; Ehara T; Nakahara S; Shibuya A; Abe T; Takita H
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):571-5. PubMed ID: 3138870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.